Why the study?
Testing for inherited and acquired thrombophilias adds to the cost of care in VTE patients, though results may not influence patient management.
Does thrombophilia testing in patients with VTE impact clinical management and what are the associated costs?
Population
266 eligible patients with VTE at Emory University Hospitals
Comparison
Patients undergoing thrombophilia testing vs those not tested
Design
Single-center retrospective study
Authors
Loading...
Routine thrombophilia testing rarely alters VTE management at high cost; leaves open value of targeted strategies.
Does thrombophilia testing in patients with VTE impact clinical management and what are the associated costs?
Thrombophilia testing in VTE patients is frequently performed but rarely impacts clinical management, resulting in high healthcare costs.
Gaddh et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: